As part of a plan to establish a network of manufacturing partners to help boost capacity ahead of a potential FDA approval of a Covid-19 vaccine, US healthcare giant...
14.02.2020
- US contract development and manufacturing organization Catalent has acquired MaSTherCell Global for $315 million cash, boosting its cell and gene therapy capabilities. The New...
29.01.2020
- Catalent has appointed Ricci Whitlow as president of its Clinical Supply Services business unit. She succeeds Paul Hegwood, who will retire in March 2020. Whitlow has over 25 years...
05.09.2019
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
05.09.2019
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
08.07.2019
- Catalent Biologics, through its Paragon Gene Therapy business, has agreed to assume the leases to two Novavax facilities in Maryland, USA. The move, said Novavax, will reduce its...
24.06.2019
- Continuing a buying spree that has added adding biologics and gene therapy capabilities to its manufacturing repertoire, California-based US drug developer Catalent is buying a...
26.04.2019
- US drug developer Catalent has announced plans to expand its integrated turnkey softgel capabilities at Eberbach, Germany, at a cost of $14 million up to 2020. The expansion...